Download PDF
Osteologie 2024; 33(01): 43-48
DOI: 10.1055/a-2161-7349
Case Report

Hyperostosis of the Clavicle as a Cardinal Symptom for Sapho Syndrome – Presentation and Discussion of a Clinical Case

Hyperostose der Klavikula als ein Kardinalsymptom für das SAPHO-Syndrom – Präsentation und Diskussion eines klinischen Fallberichtes
Julian Ramin Andresen 
1   Department of Orthopedics and Trauma Surgery, Medical University of Vienna, Vienna, Austria
,
Justyna Reinke
2   Clinic of Trauma and Restorative Surgery, Charité University Medicine, Campus Benjamin Franklin, Berlin, Germany
,
Sebastian Radmer
3   Specialist practice for orthopedics, Centre for Orthopaedics, Berlin, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

SAPHO syndrome comprises a broad clinical spectrum and is based on inflammatory osteitis with or without association to a dermatological affection. A young man with chronic recurrent osteomyelitis (CRMO) of the right clavicle as a cardinal symptom of SAPHO syndrome is reported on. Whole-body MRI has proven effective for focal detection and assessment of local activity of a possible multifocal manifestation of CRMO. Multiple medication with NSAIDs, a bisphosphonate, vitamin D substitution and antibiosis resulted in extensive remission of symptoms. Biologicals can also be used if there is no effect. The terminology of chronic nonbacterial osteomyelitis (CNO) in connection with the SAPHO syndrome is discussed.

Zusammenfassung

Das SAPHO-Syndrom umfasst ein breites klinisches Spektrum und beruht auf einer entzündlichen Osteitis mit oder ohne Assoziation zu einer dermatologischen Affektion. Es wird über einen jungen Mann mit einer chronisch rekurrierenden Osteomyelitis (CRMO) der rechten Klavikula als ein Kardinalsymptom für das SAPHO-Syndrom berichtet. Zur Fokussuche und Beurteilung einer lokalen Aktivität einer möglichen multifokalen Manifestation der CRMO hat sich das Ganzkörper-MRT bewährt. Eine multifaktorielle Medikation mit NSAR, einem Bisphosphonat, einer Vitamin D Substitution und einer Antibiose führten zu einer weitgehenden Remission der Beschwerden. Biologika können bei einem ausbleibenden Effekt zusätzlich zum Einsatz kommen. Auf die Begrifflichkeit der chronischen nichtbakteriellen Osteomyelitis (CNO) im Zusammenhang mit dem SAPHO-Syndrom wird eingegangen.

Key words

Acne - chronic recurrent multifocal osteomyelitis - hyperostosis - SAPHO syndrome - synovitis

Schlüsselwörter

Akne - chronisch rekurrierende multifokale Osteomyelitis - Hyperostose - SAPHO-Syndrom - Synovitis


Publication History

Received: 25 June 2023

Accepted: 28 August 2023

Article published online:
06 October 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. Le syndrome acné pustulose hyperostose ostéite (SAPHO). Résultats d’une enquête nationale. 85 observations. Rev Rhum Mal Osteoartic 1987; 54: 187-196 PMID: 2954204
    PubMedSearch in Google Scholar
  • 2 Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis 2020; 12: 1759720X20912865
    Search in Google Scholar
  • 3 Schilling F, Kessler S. [SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases]. Z Rheumatol 2000; 59: 1-28 German
    CrossrefPubMedSearch in Google Scholar
  • 4 Sartoris DJ, Schreiman JS, Kerr R, Resnik CS, Resnick D. Sternocostoclavicular hyperostosis: a review and report of 11 cases. Radiology 1986; 158: 125-128
    CrossrefPubMedSearch in Google Scholar
  • 5 Schilling F, Kessler S, Eckardt A, Stofft E. [„Sympathetic Arthritis” – A symptom of chronic recurrent multifocal osteomyelitis (CRMO)]. Akt Rheumatol 2001; 26: 61-74 German
    Thieme ConnectSearch in Google Scholar
  • 6 Klemm P, Lange U. [SAPHO syndrome: An overview and nosological differentiation of 35 disease cases]. Z Rheumatol 2021; 80: 456-466 German
    CrossrefPubMedSearch in Google Scholar
  • 7 Collert S, Isacson J. Chronic sclerosing osteomyelitis (Garré). Clin Orthop Relat Res 1982; 164: 136-140 PMID: 7067276
    CrossrefSearch in Google Scholar
  • 8 Jurik AG, Egund N. MRI in chronic recurrent multifocal osteomyelitis. Skeletal Radiol 1997; 26: 230-238
    CrossrefPubMedSearch in Google Scholar
  • 9 Azouz EM, Jurik AG, Bernard C. Sternocostoclavicular hyperostosis in children: a report of eight cases. AJR Am J Roentgenol 1998; 171: 461-466
    CrossrefPubMedSearch in Google Scholar
  • 10 Jurik AG, Møller BN. Chronic sclerosing osteomyelitis of the clavicle. A manifestation of chronic recurrent multifocal osteomyelitis. Arch Orthop Trauma Surg (1978) 1987; 106: 144-151
    CrossrefPubMedSearch in Google Scholar
  • 11 Andronikou S, Mendes da Costa T, Hussien M, Ramanan AV. Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns. Clin Radiol 2019; 74: 737.e3-737.e15
    CrossrefPubMedSearch in Google Scholar
  • 12 Sergi CM, Miller E, Demellawy DE, Shen F, Zhang M. Chronic recurrent multifocal osteomyelitis. A narrative and pictorial review. Front Immunol 2022; 13: 959575
    CrossrefPubMedSearch in Google Scholar
  • 13 Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 2013; 11: 47
    CrossrefPubMedSearch in Google Scholar
  • 14 Leerling AT, Cañete AN, Ramautar AIE, Appelman-Dijkstra NM, Winter EM. Sternocostoclavicular hyperostosis: Positive clinical and radiological response on pamidronate. Front Endocrinol (Lausanne) 2021; 12: 621604
    CrossrefPubMedSearch in Google Scholar
  • 15 Roderick M, Shah R, Finn A, Ramanan AV. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford) 2014; 53: 1973-1976
    CrossrefPubMedSearch in Google Scholar
  • 16 Colina M, Trotta F. Antibiotics may be useful in the treatment of SAPHO syndrome. Mod Rheumatol 2014; 24: 697-698
    CrossrefPubMedSearch in Google Scholar
  • 17 Przepiera-Będzak H, Brzosko M. Clinical symptoms, imaging, and treatment of SAPHO syndrome: a single‑center study of 52 cases. Pol Arch Intern Med 2018; 128: 396-399
    CrossrefPubMedSearch in Google Scholar
  • 18 Schilling F, Eckardt A, Kessler S. [Chronic recurrent multifocal osteomyelitis]. Z Orthop Ihre Grenzgeb 2000; 138: 530-539 German
    Thieme ConnectPubMedSearch in Google Scholar
  • 19 Aden S, Wong S, Yang C, Bui T, Higa T, Scheck J, Iyer RS, Egbert M, Lindberg A, Zhao Y. Increasing cases of chronic nonbacterial osteomyelitis in children: A Series of 215 cases from a single tertiary referral center. J Rheumatol 2022; 49: 929-934
    CrossrefPubMedSearch in Google Scholar
  • 20 Hetrick R, Oliver M. Pediatric autoinflammatory bone disorders-a mini review with special focus on pathogenesis and inborn errors of immunity. Front Pediatr 2023; 11: 1169659
    CrossrefPubMedSearch in Google Scholar
  • 21 Przepiera-Będzak H, Brzosko M. SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review. Postepy Dermatol Alergol 2021; 38: 937-942
    CrossrefPubMedSearch in Google Scholar
  • 22 Andronikou S, Kraft JK, Offiah AC, Jones J, Douis H, Thyagarajan M, Barrera CA, Zouvani A, Ramanan AV. Whole-body MRI in the diagnosis of paediatric CNO/CRMO. Rheumatology (Oxford) 2020; 59: 2671-2680
    CrossrefPubMedSearch in Google Scholar
  • 23 Nico MAC, Araújo FF, Guimarães JB, da Cruz IAN, Silva FD, Carneiro BC, Filho AGO. Chronic nonbacterial osteomyelitis: the role of whole-body MRI. Insights Imaging 2022; 13: 149
    CrossrefPubMedSearch in Google Scholar
  • 24 Aydıngöz Ü, Yıldız AE. MRI in the diagnosis and treatment response assessment of chronic nonbacterial osteomyelitis in children and adolescents. Curr Rheumatol Rep 2022; 24: 27-39
    CrossrefPubMedSearch in Google Scholar
  • 25 Gupta AK, Skinner AR. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89
    CrossrefPubMedSearch in Google Scholar
  • 26 Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford) 2006; 45: 730-733
    CrossrefPubMedSearch in Google Scholar
  • 27 Burgemeister LT, Baeten DL, Tas SW. Biologics for rare inflammatory diseases: TNF blockade in the SAPHO syndrome. Neth J Med 2012; 70: 444-449 PMID: 23230013.
    PubMedSearch in Google Scholar
  • 28 Kamata Y, Minota S. Successful treatment of a patient with SAPHO syndrome with certolizumab pegol. Rheumatol Int 2015; 35: 1607-1608
    CrossrefPubMedSearch in Google Scholar
  • 29 Zhang L, Gao Z. Etanercept in the treatment of refractory SAPHO syndrome. Am J Clin Exp Immunol 2016; 5: 62-66 PMID: 28078192.
    PubMedSearch in Google Scholar
  • 30 Yang Q, Xiang T, Wu Y, Ye E, He B, Bu Z. SAPHO Syndrome with palmoplantar pustulosis as the first manifestation successfully treated with adalimumab. Clin Cosmet Investig Dermatol 2022; 15: 2547-2554
    CrossrefPubMedSearch in Google Scholar
  • 31 Sato H, Wada Y, Hasegawa E, Nozawa Y, Nakatsue T, Ito T, Kuroda T, Saeki T, Umezu H, Suzuki Y, Nakano M, Narita I. Adult-onset chronic recurrent multifocal osteomyelitis with high intensity of muscles detected by magnetic resonance imaging, successfully controlled with tocilizumab. Intern Med 2017; 56: 2353-2360
    CrossrefPubMedSearch in Google Scholar
  • 32 Cheng W, Li F, Tian J, Xie X, Chen JW, Peng XF, Tang Q, Ge Y. New Insights in the treatment of SAPHO Syndrome and medication recommendations. J Inflamm Res 2022; 15: 2365-2380
    CrossrefPubMedSearch in Google Scholar
  • 33 Leerling AT, Dekkers OM, Appelman-Dijkstra NM, Winter EM. Clinical and therapeutic diversity in adult chronic nonbacterial osteomyelitis (CNO) of the sternocostoclavicular region: a meta-analysis. Rheumatology (Oxford) 2023; 62: 512-522
    CrossrefPubMedSearch in Google Scholar